Related Experiment Video
Updated: May 28, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Low molecular weight heparin: a practical approach in deep venous thrombosis in palliative care
Samrat Dutta1, Subrata Chattopadhayay, C Dasgupta
1Department of Radiotherapy, Medical College and Hospital, Kolkata, India.
Introduction:
Deep vein thrombosis (DVT) is one of the many cause of pain in advance cases of carcinoma cervix. The most widely used agent for combating DVT is unfractionated heparin.
Aims:
Aims of this study is to see the efficacy of the use of low molecular weight (LMW) haparin and its practical utility in palliative care settings.
Materials And Methods:
Twelve cases of established DVT received enoxaparin at 40 mg/m with warfarin.
Results:
There was 70% resolution of limb swelling in seven cases. Out of remaining four cases took two months to resolve and one case did not resolve completely.
Conclusions:
LMV heparin is effective in palliative care setting and also has added advantage of subcutaneous route of administration.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism III: Nursing Management
